17-alpha-hydroxyprogesterone has been researched along with buserelin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (36.36) | 18.7374 |
| 1990's | 11 (50.00) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Sutter, P; Dhont, M; Vandekerckhove, D; Vanluchene, E | 1 |
| Beconcini, D; Cristiani, G; Fioretti, P; Fruzzetti, F; Mais, V; Melis, GB; Mian, E; Paoletti, AM | 1 |
| Ayub, M; Levell, MJ | 1 |
| Bailey, JD; Fazekas, AT; Fishman, L; Holland, FJ | 1 |
| Brekke, I; Hansson, V; Jegou, B; Naess, O; Torjesen, P | 1 |
| Calogero, A; Coniglione, F; D'Agata, R; Macchi, M; Mongioi, A; Recupero, D; Sipione, C; Vicari, E | 1 |
| Benraad, TJ; Boers, GH; Hermus, AR; Kloppenborg, PW; Pieters, GF; Raemaekers, JM; Smals, AE; Smals, AG | 1 |
| Faure, N; Lemay, A | 1 |
| Beaur, A; Bourreau, E; Parinaud, J; Pontonnier, G; Vieitez, G | 1 |
| Bélanger, A; Dubé, JY; Frenette, G; Labrie, F; Tremblay, RR; Tremblay, Y | 1 |
| Jung, C; Kuhl, H; Taubert, HD | 1 |
| Donaldson, A; Franks, S; Leigh, A; White, D; Wilson, C | 1 |
| Keleştimur, F; Sahin, Y | 3 |
| Loumaye, E; Shoham, Z; Weissman, A | 1 |
| Ambrosi, B; Bochicchio, D; Ferrario, R; Passini, E; Re, T | 1 |
| Ayata, D; Keleştimur, F; Sahin, Y | 1 |
| Bayram, F; Keleştimur, F; Sahin, Y; Tutuş, A; Unlühizarci, K | 1 |
| Caputo, M; Castello, R; Moghetti, P; Muggeo, M; Negri, C; Perrone, F; Tosi, F; Zanolin, E | 1 |
| Cognigni, GE; Gambineri, A; Pasquali, R; Patton, L; Pocognoli, P | 1 |
| Ciampaglia, W; Cognigni, GE; Fanelli, F; Gambineri, A; Pagotto, U; Pasquali, R; Patton, L; Prontera, O | 1 |
2 trial(s) available for 17-alpha-hydroxyprogesterone and buserelin
| Article | Year |
|---|---|
Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Buserelin; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Corpus Luteum; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Hypogonadism; Infertility, Female; Luteinizing Hormone; Menotropins; Ovulation Induction; Pregnancy; Progesterone | 1996 |
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Blood Glucose; Buserelin; Cholesterol; Double-Blind Method; Endocrine Glands; Female; Glucose Clamp Technique; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin Resistance; Menstruation Disturbances; Metformin; Polycystic Ovary Syndrome; Triglycerides | 2000 |
20 other study(ies) available for 17-alpha-hydroxyprogesterone and buserelin
| Article | Year |
|---|---|
Correlations between follicular fluid steroid analysis and maturity and cytogenetic analysis of human oocytes that remained unfertilized after in vitro fertilization.
Topics: 17-alpha-Hydroxyprogesterone; 20-alpha-Dihydroprogesterone; Androstenedione; Buserelin; Chromosomes; Clomiphene; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Goserelin; Humans; Hydroxyprogesterones; Karyotyping; Male; Menotropins; Oocytes; Ploidies; Progesterone; Progestins; Steroids | 1991 |
High testosterone levels of ovarian origin affect adrenal steroidogenesis?
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydrocortisone; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Testosterone | 1991 |
Suppression of plasma androgens by the antiandrogen flutamide in prostatic cancer patients treated with Zoladex, a GnRH analogue.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androgens; Androstenedione; Anilides; Antineoplastic Agents; Buserelin; Dehydroepiandrosterone; Depression, Chemical; Flutamide; Goserelin; Humans; Hydroxyprogesterones; Male; Orchiectomy; Prostatic Neoplasms; Testosterone | 1990 |
Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Buserelin; Child Behavior; Child, Preschool; Drug Resistance; Follicle Stimulating Hormone; Growth; Humans; Hydroxyprogesterones; Ketoconazole; Luteinizing Hormone; Male; Puberty, Precocious; Testosterone | 1985 |
Properties and regulation of GnRH receptors in the anterior pituitary and the testis of the rat: different response of Leydig cell LH and GnRH receptors to hormonal treatments.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Binding Sites; Buserelin; Dexamethasone; Estradiol; Gonadotropin-Releasing Hormone; Hormones; Hydroxyprogesterones; Kinetics; Leydig Cells; Male; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LH; Receptors, LHRH; Substrate Specificity; Testis; Testosterone | 1985 |
Failure of GnRH analogue to inhibit serum concentrations of testosterone and 17 alpha-hydroxyprogesterone in hCG-substituted hypogonadotropic hypogonadism.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Buserelin; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Humans; Hydroxyprogesterones; Hypogonadism; Male; Testis; Testosterone | 1986 |
Reciprocal inhibition of the long-acting luteinizing hormone releasing hormone agonist Buserelin and human chorionic gonadotropin in stimulating Leydig cell steroidogenesis.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Gonadal Steroid Hormones; Humans; Hydroxyprogesterones; Leydig Cells; Male; Middle Aged; Testosterone | 1987 |
Ovarian suppression in polycystic ovarian disease during 6 month administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Buserelin; Estradiol; Female; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Polycystic Ovary Syndrome; Time Factors | 1987 |
Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Buserelin; Cells, Cultured; Cholesterol, LDL; Estradiol; Female; Follicle Stimulating Hormone; Granulosa Cells; Humans; Hydroxyprogesterones; Progesterone; Testosterone | 1988 |
Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Buserelin; Castration; Dihydrotestosterone; Dogs; Estrogens; Hydroxyprogesterones; Male; Progesterone; Prostatic Hyperplasia; Testis; Testosterone | 1984 |
Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Buserelin; Contraceptive Agents, Female; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Luteinizing Hormone; Testosterone | 1984 |
Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Anovulation; Buserelin; Dexamethasone; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone | 1995 |
17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Adult; Buserelin; Dexamethasone; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Testosterone | 1993 |
Value of buserelin testing in the evaluation of hirsute women.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Adult; Buserelin; Case-Control Studies; Evaluation Studies as Topic; Female; Hirsutism; Humans; Hyperandrogenism; Receptors, LHRH | 1996 |
Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Buserelin; C-Peptide; Female; Follicle Stimulating Hormone; Glucose; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Hyperinsulinism; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Steroid 17-alpha-Hydroxylase; Testosterone; Time Factors | 1997 |
17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Buserelin; Cytochrome P-450 Enzyme System; Female; Humans; Injections, Intravenous; Ovary; Polycystic Ovary Syndrome; Reference Values; Steroid 17-alpha-Hydroxylase | 1997 |
Relationship of ovarian stromal volume and serum 17-hydroxyprogesterone concentrations in patients with PCOS.
Topics: 17-alpha-Hydroxyprogesterone; Biomarkers; Buserelin; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Ovary; Polycystic Ovary Syndrome | 1999 |
The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Buserelin; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric | 1999 |
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Anthropometry; Blood Glucose; Buserelin; C-Peptide; Cosyntropin; Dexamethasone; Female; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Hormones; Humans; Hyperandrogenism; Insulin; Middle Aged; Ovarian Diseases; Phenotype; Polycystic Ovary Syndrome; Prospective Studies | 2007 |
Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Body Mass Index; Buserelin; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Middle Aged; Ovary; Polycystic Ovary Syndrome; Proteins; Young Adult | 2011 |